Update on hypoparathyroidism
Authors:
- 1 July 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 31 (4) , 381-387
Abstract
Purpose of review: Hypoparathyroidism is a rare endocrine disorder characterized by low or insufficient parathyroid hormone (PTH) concentrations leading to hypocalcemia, hyperphosphatemia, and markedly reduced bone turnover. Despite being a rare disease, hypoparathyroidism has a profound impact on affected patients. Recent findings: Recent epidemiologic surveys demonstrate a prevalence of between 5.3 and 40/100 000, confirming the orphan status of this disease. There is a female predominance, and anterior neck surgery is the most common etiology. Recent studies have better elucidated the chronic manifestations of the disease, impacting quality of life and multiple organ systems including the renal, cardiovascular, and skeletal systems. There are now data on longer term use of parathyroid hormone (PTH) and PTH analogs. Summary: This review focuses on recent contributions to the literature on the prevalence and epidemiology of the disease, risk of chronic manifestations, and treatment with PTH(1-34) and rhPTH(1-84). Further research is needed to determine the pathophysiology of complications in hypoparathyroidism and whether interventions can decrease future risk of these complications. In addition, further data are needed with regards to more physiologic dosing regimens and long-term treatment with PTH and PTH analogs.Keywords
This publication has 39 references indexed in Scilit:
- CorrigendaThe Journal of Clinical Endocrinology & Metabolism, 2015
- Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 studyThe Lancet Diabetes & Endocrinology, 2013
- Prevalence and Incidence of Hypoparathyroidism in the United States Using a Large Claims DatabaseJournal of Bone and Mineral Research, 2013
- Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up studyJournal of Bone and Mineral Research, 2013
- Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral densityBMC Endocrine Disorders, 2013
- Long-Term Follow-Up of Patients with HypoparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2012
- PTH(1–84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidismJournal of Bone and Mineral Research, 2011
- Elevated cytokine production restores bone resorption by human Btk-deficient osteoclastsJournal of Bone and Mineral Research, 2010
- Dynamic and Structural Properties of the Skeleton in HypoparathyroidismJournal of Bone and Mineral Research, 2008
- Identification and Functional Expression of a Receptor Selectively Recognizing Parathyroid Hormone, the PTH2 ReceptorJournal of Biological Chemistry, 1995